1,231 findings · Cellular
- CellularStrong
Metformin failed to prove beneficial effects in MASLD progression.
Avoid using metformin for treating MASLD progression as it has not shown benefits.
Refutes 2025New - CellularStrong
Adipocyte and preadipocyte formation in scABD and scFEM depots correlates positively with VAT/TAT.
Understanding the relationship between adipocyte formation and VAT/TAT can inform strategies for managing obesity.
Supports 2017 - CellularStrong
Glucose is essential for the functioning of the pentose phosphate pathway (PPP) and cannot be substituted by other metabolites.
Practitioners should recognize the critical role of glucose in metabolic pathways.
Supports 2020 - CellularStrong
Semaglutide improves the function and inflammatory status of endothelial progenitor cells (EPCs) by inhibiting LPS-induced macrophage expression of miR-155 in exosomes.
Semaglutide may be beneficial in improving endothelial function in obesity-related inflammation.
Supports 2023 - CellularStrong
LPS-induced macrophage exosomes reduce the cellular activity, migratory capacity, and tube-forming ability of EPCs.
Inflammation from macrophage exosomes can impair endothelial repair mechanisms.
Supports 2023 - CellularStrong
Women with PCOS exhibited approximately 80% lower expression of perilipins PLIN1, PLIN3, and PLIN5 compared to controls.
Women with PCOS may have impaired lipolysis due to lower perilipin expression.
Supports 2014 - CellularStrong
Chocolate milk did not enhance skeletal muscle hypertrophy following training.
Chocolate milk is not an effective supplement for enhancing muscle growth post-training.
Refutes 2014 - CellularStrong
ΔMfn2 enhances respiratory control ratio in mouse skeletal muscle.
This indicates potential for improving muscle energy efficiency.
Supports 2013 - CellularStrong
Semaglutide alleviated metabolic disorders, ameliorated myocardial fibrosis, improved cardiac function, antagonized oxidative stress, and suppressed cardiomyocyte apoptosis in diabetic mice.
Semaglutide may be beneficial for improving heart health in diabetic patients.
Supports 2024 - CellularStrong
Whey and pea protein compared to water supplementation had no significant effects on post-exercise delayed onset of muscle soreness (DOMS) and fitness tests.
Protein supplementation may not significantly reduce muscle soreness or improve fitness performance after exercise.
Refutes 2020 - CellularStrong
Gastrointestinal adverse events occur commonly with semaglutide, and other serious adverse events have been reported.
Healthcare providers should monitor patients for gastrointestinal and other serious adverse events while on semaglutide.
Supports 2023 - CellularStrong
There are existing knowledge gaps in the molecular and cellular processes underlying exercise-induced benefits and adaptations.
Researchers should focus on addressing these gaps to advance the understanding of exercise physiology.
Supports 2022 - CellularStrong
Fructose resets ATP levels to a lower level in the cell, suppressing mitochondrial function.
Understanding fructose's impact on ATP may inform dietary recommendations.
Supports 2023 - CellularStrong
The development of new drug combinations may provide alternative treatment options for OSA.
Practitioners should explore new drug combinations as potential treatments for OSA.
Supports 2023 - CellularStrong
Tirzepatide treatment significantly decreased Alt-Ext-induced IL-5 and IL-13 levels in lung homogenates compared with vehicle treatment.
Tirzepatide may help reduce allergic inflammation in obese asthma patients.
Supports 2022 - CellularStrong
There was no benefit from ILI for individuals in the third tertile of frailty index, with a hazard ratio of 1.15.
Practitioners should be cautious in recommending intensive lifestyle interventions for more frail individuals.
Supports 2020 - CellularStrong
The incidence of gastrointestinal adverse effects with tirzepatide was similar to that of semaglutide.
Tirzepatide may have a similar safety profile regarding gastrointestinal effects compared to semaglutide.
Supports 2022 - CellularStrong
A biomimetic and comparative approach can provide insights into human ageing processes.
Practitioners should consider integrating insights from diverse species to enhance understanding of ageing.
Supports 2021 - CellularStrong
There is a need for renewed focus in the pathophysiology of ageing and age-related disease.
Researchers should explore new avenues in the study of ageing and related diseases.
Supports 2021 - CellularStrong
Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the global population.
Healthcare providers should be aware of the high prevalence of NAFLD in their patient populations.
Supports 2020 - CellularStrong
The most common adverse events associated with semaglutide are gastrointestinal in nature.
Healthcare providers should inform patients about potential gastrointestinal side effects when prescribing semaglutide.
Supports 2024 - CellularStrong
Ex-DARPin fusion proteins significantly improved the survival of pancreatic islets in diabetic mice.
Improving pancreatic islet survival could enhance insulin production and overall diabetes management.
Supports 2023 - CellularStrong
Patients with coronary artery disease (CAD) have a lower capillary-to-fiber ratio (C/Fi) and capillary-to-fiber perimeter exchange (CFPE) index in Type II fibers compared to healthy controls.
Understanding these differences can inform targeted rehabilitation strategies for CAD patients.
Supports 2020 - CellularStrong
There is a complex and bidirectional relationship between adipose and breast tissues.
Understanding this relationship can help in developing targeted interventions for breast cancer.
Supports 2023